semaglutide addiction Drug Abuse - tirzepatide-is-a-glp-1 substance abuse Semaglutide Addiction: A Developing Understanding of a Promising Therapeutic Avenue

semaglutide-league-city The landscape of addiction treatment is continually evolving, and recent research is shining a light on the potential of semaglutide, a medication primarily known for its efficacy in managing type 2 diabetes (T2D) and obesity, to also address various forms of addictionDo New Obesity and Diabetes Drugs Also Curb Drinking .... While initially developed for metabolic disorders, the GLP-1 receptor agonists (GLP-1 RAs) class of drugs, to which semaglutide belongs, is exhibiting unexpected yet significant benefits in reducing cravings and compulsive behaviors associated with substance abuse and other addictive disorders. This emerging understanding positions semaglutide as a potentially powerful tool in the fight against drug abuse and addiction.

The Science Behind Semaglutide's Impact on Addiction

Semaglutide, marketed under brand names like Ozempic and Wegovy, functions by mimicking the action of the glucagon-like peptide-1 (GLP-1) hormone. This hormone plays a crucial role in regulating blood sugar and promoting satiety. However, scientific investigations are uncovering that GLP-1 pathways extend beyond metabolic control, influencing areas of the brain associated with reward, motivation, and craving.

Clinical trials have demonstrated that semaglutide can significantly reduce alcohol consumptionSemaglutide Therapy for Alcohol Reduction (STAR). A notable randomized controlled trial published in JAMA Psychiatry in 2025, authors *CS Hendershot* and colleagues, found that once-weekly semaglutide in adults with alcohol use disorder (AUD) led to significant reductions in both the number of days of heavy drinking and weekly alcohol craving.What will happen during the study? Participants will visit the National Institute onDrug Abuse(NIDA) in Baltimore once a week for about 20 weeks (5 months). The study reported ß (beta) values of -0.39 (95% CI, -0.73 to -0.A study in Sweden found that people with alcohol use disorder and type two diabetes who tooksemaglutidewere less likely to be hospitalized for issues related ...06; P = .01), indicating a statistically significant decrease in craving over time. This research, building on initial real-world evidence from studies involving patients with obesity taking semaglutide or tirzepatide medications, provides robust data on semaglutide and alcohol use.

Furthermore, preliminary studies, including phase 2 clinical trials, suggest that semaglutide can curb cravings for substances beyond alcohol. Research indicates potential benefits in reducing cigarette consumption and even impacting compulsive behaviors like gambling.作者：F Quddos·2023·被引用次数：130—We provide initial real-world evidence of reduced alcohol consumption in people with obesity takingSemaglutideor Tirzepatide medications. A study by *F Quddos* and colleagues (2023) highlights the potential of semaglutide and tirzepatide in reducing alcohol consumption among individuals with obesity. Another investigation by *VM Romeo* and colleagues (2025) explored the use of semaglutide in a patient with cocaine use, suggesting its potential in addressing substance abuse, particularly when co-occurring with obesity.

Semaglutide: A Multifaceted Approach to Addiction Treatment

The implications of semaglutide's impact on addiction are far-reaching. It offers a novel approach that may address underlying biological mechanisms driving addictive behaviors. By modulating reward pathways, stress responses, and cognitive functions, semaglutide appears to reduce the intense desire and compulsion associated with various addictions. This represents a significant shift from conventional addiction treatment, which often focuses on behavioral therapies and direct withdrawal management.2024年4月24日—People worldwide are taking drugs like Ozempic to lose weight. The Florey's Dr Leigh Walker and Dr Roberta Anversa investigate the rise and ...

The positive effects of semaglutide are not limited to severe alcohol use disorder (AUD)Can GLP-1 agonists help treat addiction?. Studies are exploring its efficacy in broader contexts.Does semaglutide cause withdrawal symptoms? - Fay For instance, research by *W Wang* and colleagues (2024) found that semaglutide, a GLP-1RA approved for type 2 diabetes (T2DM) in 2017 and obesity in 2021, reduced drinking and relapse in individuals taking the medication. This highlights its potential to help people cut down on their alcohol intake, as noted in research published in February 2025.Does Wegovy (Semaglutide) Help with Alcohol De- ...

Expert Opinions and Future Directions

Leading experts in addiction psychiatry are recognizing the potential of semaglutide and other GLP-1 drugs. Psychiatrist *Anna Lembke* from Stanford Medicine, in her insights from April 2025, unpacks the potential of FDA-approved weight-reducing GLP-1 drugs like Ozempic as valuable tools in treating addictionFive things to know about GLP-1s and addiction. She suggests that these drugs go far beyond weight loss and demonstrate a surprising ability to tame cravings for a wide range of addictive substances and behaviors.

The clinical trial "Semaglutide Therapy for Alcohol Reduction (STAR)" further exemplifies the commitment to understanding this therapeutic avenue. Participants in this study visit the National Institute on Drug Abuse (NIDA) in Baltimore for approximately 20 weeks, contributing valuable data to this growing field.

While the evidence is promising, it's important to note that semaglutide is not a universal cure for addiction. The research is ongoing, with many studies being preliminary or in phase 2 trials.Effects of once‐weekly semaglutide on appetite, energy intake, control ... Questions regarding optimal dosing, long-term efficacy, potential withdrawal symptoms, and psychiatric adverse events associated with semaglutide, liraglutide, and other similar medications are still being thoroughly investigated by the medical communityOnce-Weekly Semaglutide in Adults With Alcohol Use .... However, the consistent findings of reduced cravings and consumption across various studies are generating significant optimism.A turning point in addiction psychiatry?

In conclusion, the exploration of semaglutide in the context of addiction represents a paradigm shift. Its capacity to influence brain pathways linked to reward and motivation, coupled with its established efficacy in weight management and diabetes control, positions it as a groundbreaking therapeutic agent. As research continues to unravel the complexities of semaglutide addiction and its broader applications, it holds the promise of offering new hope and effective treatment options for individuals struggling with substance abuse and other compulsive disorders.